(Q47642249)

4 February 2018

title

Very long-chain n-3 fatty acids and human health: fact, fiction and the future. (English)

1 reference

4 February 2018

author

Philip Calder

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29039280%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

author name string

P C Calder

series ordinal

1

1 reference

4 February 2018

publication date

17 October 2017

1 reference

4 February 2018

Proceedings of the Nutrition Society

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29039280%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

volume

77

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29039280%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29039280%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

page(s)

52-72

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29039280%20AND%20SRC:MED&resulttype=core&format=json

Metabolism of stearidonic acid in human subjects: comparison with the metabolism of other n−3 fatty acids

4 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Modifying the lipid content and composition of plant seeds: engineering the production of LC-PUFA.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Effects of eicosapentaenoic acid versus docosahexaenoic acid on serum lipids: a systematic review and meta-analysis.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

The independent effects of eicosapentaenoic acid and docosahexaenoic acid on cardiovascular risk factors in humans

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Effect of long-term omega 3 polyunsaturated fatty acid supplementation with or without multidomain intervention on cognitive function in elderly adults with memory complaints (MAPT): a randomised, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

No Effect of Omega-3 Fatty Acid Supplementation on Cognition and Mood in Individuals with Cognitive Impairment and Probable Alzheimer's Disease: A Randomised Controlled Trial.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Ethyl-EPA in Alzheimer's disease--a pilot study

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Effects of n-3 fatty acids, EPA v. DHA, on depressive symptoms, quality of life, memory and executive function in older adults with mild cognitive impairment: a 6-month randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Regional membrane phospholipid alterations in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

The effect of docosahexaenoic acid on aggression in elderly Thai subjects--a placebo-controlled double-blind study

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

The effect of docosahexaenoic acid on aggression in young adults. A placebo-controlled double-blind study

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

A randomized controlled study of the efficacy of six-month supplementation with concentrated fish oil rich in omega-3 polyunsaturated fatty acids in first episode schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

A placebo-controlled trial of omega-3 fatty acid (ethyl eicosapentaenoic acid) supplementation for residual symptoms and cognitive impairment in schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Two double-blind placebo-controlled pilot studies of eicosapentaenoic acid in the treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Red blood cell polyunsaturated fatty acids measured in red blood cells and schizophrenia: a meta-analysis

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

A red cell membrane abnormality in a subgroup of schizophrenic patients: evidence for two diseases.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Omega-3 for bipolar disorder: meta-analyses of use in mania and bipolar depression

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Meta-Analysis of the Effects of Eicosapentaenoic Acid (EPA) in Clinical Trials in Depression

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Do Omega-3/6 Fatty Acids Have a Therapeutic Role in Children and Young People with ADHD?

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

A randomized, placebo controlled trial of omega-3 fatty acids in the treatment of young children with autism

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Omega-3/omega-6 fatty acids for attention deficit hyperactivity disorder: a randomized placebo-controlled trial in children and adolescents

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Omega-3 fatty acids supplementation in children with autism: a double-blind randomized, placebo-controlled pilot study.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Behavioral effects of omega-3 fatty acid supplementation in young adults with severe autism: an open label study

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

A pilot randomized controlled trial of omega-3 fatty acids for autism spectrum disorder

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Effect of docosahexaenoic acid-containing food administration on symptoms of attention-deficit/hyperactivity disorder - a placebo-controlled double-blind study

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

A randomized, double-blind, placebo-controlled trial of docosahexaenoic acid supplementation in children with attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Reduced Symptoms of Inattention after Dietary Omega-3 Fatty Acid Supplementation in Boys with and without Attention Deficit/Hyperactivity Disorder

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Effects of an open-label pilot study with high-dose EPA/DHA concentrates on plasma phospholipids and behavior in children with attention deficit hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Role of polyunsaturated fatty acids in the management of Egyptian children with autism

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Effects of large doses of arachidonic acid added to docosahexaenoic acid on social impairment in individuals with autism spectrum disorders: a double-blind, placebo-controlled, randomized trial.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

EFA supplementation in children with inattention, hyperactivity, and other disruptive behaviors

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Visual, cognitive, and language assessments at 39 months: a follow-up study of children fed formulas containing long-chain polyunsaturated fatty acids to 1 year of age.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Docosahexaenoic acid and visual functioning in preterm infants: a review

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Effect of long-chain n-3 fatty acid supplementation on visual acuity and growth of preterm infants with and without bronchopulmonary dysplasia

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Visual acuity and fatty acid status of term infants fed human milk and formulas with and without docosahexaenoate and arachidonate from egg yolk lecithin

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Effect of dietary omega-3 fatty acids on retinal function of very-low-birth-weight neonates

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Nutritional modulation of cognitive function and mental health

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Mechanisms of action of docosahexaenoic acid in the nervous system

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Can Early Omega-3 Fatty Acid Exposure Reduce Risk of Childhood Allergic Disease?

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

The effect of perinatal omega-3 fatty acid supplementation on inflammatory markers and allergic diseases: a systematic review

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Omega-3 long-chain PUFA intake during pregnancy and allergic disease outcomes in the offspring: a systematic review and meta-analysis of observational studies and randomized controlled trials.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Effect of n-3 long chain polyunsaturated fatty acid supplementation in pregnancy on infants' allergies in first year of life: randomised controlled trial

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Fish oil supplementation in pregnancy and lactation may decrease the risk of infant allergy.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Increased intake of oily fish in pregnancy: effects on neonatal immune responses and on clinical outcomes in infants at 6 mo

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Fish oil supplementation in pregnancy modifies neonatal allergen-specific immune responses and clinical outcomes in infants at high risk of atopy: a randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Randomized, placebo-controlled study of ethyl-eicosapentaenoic acid as supplemental treatment in schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Is there a role for fatty acids in early life programming of the immune system?

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Dietary factors and low-grade inflammation in relation to overweight and obesity

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Clinical trials of fatty acid treatment in ADHD, dyslexia, dyspraxia and the autistic spectrum

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

The immune system in atherosclerosis

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Atherosclerosis — An Inflammatory Disease

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Inflammatory disease processes and interactions with nutrition

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Double-blind, placebo-controlled, randomized study of eicosapentaenoic acid diester in patients with cancer cachexia

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Lean body mass gain in patients with head and neck squamous cell cancer treated perioperatively with a protein- and energy-dense nutritional supplement containing eicosapentaenoic acid

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Improving outcome of chemotherapy of metastatic breast cancer by docosahexaenoic acid: a phase II trial.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Supplementation with fish oil increases first-line chemotherapy efficacy in patients with advanced nonsmall cell lung cancer

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Oral nutritional supplements containing n-3 polyunsaturated fatty acids affect quality of life and functional status in lung cancer patients during multimodality treatment: an RCT.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Effects of eicosapentaenoic and docosahexaenoic n-3 fatty acids from fish oil and preferential Cox-2 inhibition on systemic syndromes in patients with advanced lung cancer

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Circulating fatty acids and prostate cancer risk: individual participant meta-analysis of prospective studies

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Dietary intake of specific fatty acids and breast cancer risk among postmenopausal women in the VITAL cohort

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Dietary fat in breast cancer survival

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

n-3 polyunsaturated fatty acids: the potential role for supplementation in cancer

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Marine polyunsaturated fatty acids and cancer therapy

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Eicosanoids and cancer

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Influences of micronutrient and omega-3 fatty acid supplementation on cognition, learning, and behavior: methodological considerations and implications for children and adolescents in developed societies

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Dietary ω -3 polyunsaturated fatty acid DHA: a potential adjuvant in the treatment of cancer

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Effects of Omega-3 fatty acid on major cardiovascular events and mortality in patients with coronary heart disease: a meta-analysis of randomized controlled trials.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Omega 3 Fatty acids and cardiovascular outcomes: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

n-3 fatty acids in patients with multiple cardiovascular risk factors

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

n-3 fatty acids and cardiovascular events after myocardial infarction

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

The modulation of ionic currents in excitable tissues by n-3 polyunsaturated fatty acids

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Purified eicosapentaenoic and docosahexaenoic acids have differential effects on serum lipids and lipoproteins, LDL particle size, glucose, and insulin in mildly hyperlipidemic men.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Effects of omega-3 fatty acids on serum markers of cardiovascular disease risk: a systematic review

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

n-3 fatty acids in cardiovascular disease

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

n-3 fatty acids and lipoproteins: comparison of results from human and animal studies

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

n-3 Fatty acids and cardiovascular disease: evidence explained and mechanisms explored

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

n-3 Fatty acids from fish or fish-oil supplements, but not alpha-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic review

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Omega-3 fatty acids and cardiac arrhythmias: prior studies and recommendations for future research: a report from the National Heart, Lung, and Blood Institute and Office Of Dietary Supplements Omega-3 Fatty Acids and their Role in Cardiac Arrhythmo

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Omega-3 fatty acids and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

ω-3 Polyunsaturated Fatty Acid Biomarkers and Coronary Heart Disease: Pooling Project of 19 Cohort Studies

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

The composition of food consumed by Greenland Eskimos.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Atherosclerosis in Alaska Natives and non-natives

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Mortality from ischaemic heart disease and cerebrovascular disease in Greenland

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Novel n-3 immunoresolvents: structures and actions

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Resolution phase lipid mediators of inflammation: agonists of resolution

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Fish Oil-Derived Fatty Acids in Pregnancy and Wheeze and Asthma in Offspring

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Specialized pro-resolving lipid mediators in the inflammatory response: An update

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Enzymes and receptors of prostaglandin pathways with arachidonic acid-derived versus eicosapentaenoic acid-derived substrates and products

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Enhanced Bioavailability of EPA From Emulsified Fish Oil Preparations Versus Capsular Triacylglycerol.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Omega-3 long chain fatty acid "bioavailability": a review of evidence and methodological considerations

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Leukotrienes and other products of the 5-lipoxygenase pathway. Biochemistry and relation to pathobiology in human diseases

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Fatty acids and inflammation: the cutting edge between food and pharma.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

n-3 fatty acids and gene expression

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Dietary polyunsaturated fatty acids and regulation of gene transcription

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

The multi-dimensional regulation of gene expression by fatty acids: polyunsaturated fats as nutrient sensors

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Fatty acids, eicosanoids and PPAR gamma.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Editorial: Fat chance to enhance B cell function

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Lipid rafts--composition, characterization, and controversies

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Revitalizing membrane rafts: new tools and insights

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Mechanisms of action of (n-3) fatty acids

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Rapid Incorporation of ω-3 Fatty Acids Into Colonic Tissue After Oral Supplementation in Patients With Colorectal Cancer

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Dietary omega-3 polyunsaturated fatty acids inhibit phosphoinositide formation and chemotaxis in neutrophils

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

The influence of different types of omega 3 polyunsaturated fatty acids on blood lipids and platelet function in healthy volunteers

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Changes in membrane lipid composition of human erythrocytes after dietary supplementation of (n-3) polyunsaturated fatty acids. Maintenance of membrane fluidity

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Effects of four doses of n-3 fatty acids given to hyperlipidemic patients for six months

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Long-term effects of dietary marine omega-3 fatty acids upon plasma and cellular lipids, platelet function, and eicosanoid formation in humans

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Lipids of ocular tissues. IV. A comparison of the phospholipids from the retina of six mammalian species

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Polyunsaturated fatty acid pattern in liver and erythrocyte phospholipids from obese patients

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Increase in long-chain polyunsaturated fatty acid n - 6/n - 3 ratio in relation to hepatic steatosis in patients with non-alcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Effects of fish-oil supplementation on myocardial fatty acids in humans

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Fatty acid composition of brain, retina, and erythrocytes in breast- and formula-fed infants.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Effect of low-to-moderate amounts of dietary fish oil on neutrophil lipid composition and function

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Incorporation of eicosapentaenoic and docosahexaenoic acids into lipid pools when given as supplements providing doses equivalent to typical intakes of oily fish.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Effect of unsaturated acids on membrane structure and enzyme kinetics

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Dietary Intake and Food Sources of EPA, DPA and DHA in Australian Children

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Dietary intakes and food sources of omega-6 and omega-3 polyunsaturated fatty acids.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Developmental quotient at 24 months and fatty acid composition of diet in early infancy: a follow up study

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Genetic variants of the fatty acid desaturase gene cluster predict amounts of red blood cell docosahexaenoic and other polyunsaturated fatty acids in pregnant women: findings from the Avon Longitudinal Study of Parents and Children

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Eicosapentaenoic and docosapentaenoic acids are the principal products of alpha-linolenic acid metabolism in young men*.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Efficacy of Souvenaid in mild Alzheimer's disease: results from a randomized, controlled trial.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Evidence for age-related differences in the fatty acid composition of human adipose tissue, independent of diet

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Metabolism and functional effects of plant-derived omega-3 fatty acids in humans.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Distribution, interconversion, and dose response of n-3 fatty acids in humans

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Omega-3 fatty acids in cancer, the protectors of good and the killers of evil?

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Bioavailability of long-chain omega-3 fatty acids

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

The Salmon in Pregnancy Study: study design, subject characteristics, maternal fish and marine n-3 fatty acid intake, and marine n-3 fatty acid status in maternal and umbilical cord blood.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Desaturation and elongation of Fatty acids and insulin action.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Fish consumption and major depression.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Conversion of alpha-linolenic acid to eicosapentaenoic, docosapentaenoic and docosahexaenoic acids in young women.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Dietary fatty acids and membrane protein function

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Essentiality of and recommended dietary intakes for omega-6 and omega-3 fatty acids

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Effect of long-chain polyunsaturated fatty acids in infant formula on problem solving at 10 months of age.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Effect of Omega-3 and -6 Supplementation on Language in Preterm Toddlers Exhibiting Autism Spectrum Disorder Symptoms.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Marine omega-3 fatty acids and inflammatory processes: Effects, mechanisms and clinical relevance

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Fatty acid analysis of blood plasma of patients with Alzheimer's disease, other types of dementia, and cognitive impairment

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

ω-3 Fatty acids for major depressive disorder in adults: an abridged Cochrane review

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Gender differences in the n-3 fatty acid content of tissues

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

The effect of three lipid emulsions differing in fatty acid composition on growth, apoptosis and cell cycle arrest in the HT-29 colorectal cancer cell line.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

A critical appraisal of the role of dietary long-chain polyunsaturated fatty acids on neural indices of term infants: a randomized, controlled trial.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

ω-3 Fatty Acid Supplementation Does Not Affect Autism Spectrum Disorder in Children: A Systematic Review and Meta-Analysis

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Pharmacokinetics of omega-3-fatty acids during ingestion of fish oil preparations

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Omega-3 polyunsaturated fatty acids augment the muscle protein anabolic response to hyperinsulinaemia-hyperaminoacidaemia in healthy young and middle-aged men and women

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Visual-acuity development in healthy preterm infants: effect of marine-oil supplementation.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Effect of ω-3 polyunsaturated fatty acids on arthritic pain: A systematic review.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Incorporation of fatty acids by concanavalin A-stimulated lymphocytes and the effect on fatty acid composition and membrane fluidity

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Differences in the fatty acid composition of the grey and white matter of different regions of the brains of patients with Alzheimer's disease and control subjects.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Polyunsaturated fatty acids and gene expression

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

The effect of maternal omega-3 (n-3) LCPUFA supplementation during pregnancy on early childhood cognitive and visual development: a systematic review and meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Red blood cell membrane dynamics in schizophrenia. II. Fatty acid composition

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Lipid rafts: bringing order to chaos

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Formula supplementation with long-chain polyunsaturated fatty acids: are there developmental benefits?

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Omega-3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology?

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Association of Dietary, Circulating, and Supplement Fatty Acids With Coronary Risk

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Reduced G protein-coupled signaling efficiency in retinal rod outer segments in response to n-3 fatty acid deficiency

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Fish oil supplementation in early infancy modulates developing infant immune responses

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Omega-3 fatty acids and risk of cognitive decline in the elderly: a meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

The influence of short-chain essential fatty acids on children with attention-deficit/hyperactivity disorder: a double-blind placebo-controlled study

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Eicosapentaenoic and docosahexaenoic acids, cognition, and behavior in children with attention-deficit/hyperactivity disorder: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

omega-3 Fatty acid treatment of women with borderline personality disorder: a double-blind, placebo-controlled pilot study

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Long-term effect of high dose omega-3 fatty acid supplementation for secondary prevention of cardiovascular outcomes: A meta-analysis of randomized, placebo controlled trials [corrected].

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Effects of B vitamins and omega 3 fatty acids on cardiovascular diseases: a randomised placebo controlled trial

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Supplementation with a fish oil-enriched, high-protein medical food leads to rapid incorporation of EPA into white blood cells and modulates immune responses within one week in healthy men and women.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Changes in consumption of omega-3 and omega-6 fatty acids in the United States during the 20th century

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

EPA supplementation improves teacher-rated behaviour and oppositional symptoms in children with ADHD.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

The nutritional significance of lipid rafts

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

A review of the effect of omega-3 polyunsaturated fatty acids on blood triacylglycerol levels in normolipidemic and borderline hyperlipidemic individuals

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Relationship between Long Chain n-3 Polyunsaturated Fatty Acids and Autism Spectrum Disorder: Systematic Review and Meta-Analysis of Case-Control and Randomised Controlled Trials.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Eicosapentaenoic acid and prevention of thrombosis and atherosclerosis?

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

A Double-Blind, Placebo-Controlled Study of the Omega-3 Fatty Acid Docosahexaenoic Acid in the Treatment of Major Depression

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Biospecimen long-chain N-3 PUFA and risk of colorectal cancer: a meta-analysis of data from 60,627 individuals

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

N-3 polyunsaturated fatty acids in coronary heart disease: a meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

N-3 polyunsaturated fatty acid regulation of hepatic gene transcription

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Long chain fatty acids and gene expression in inflammation and immunity.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Effect of omega-3 polyunsaturated fatty acid supplementation on semen profile and enzymatic anti-oxidant capacity of seminal plasma in infertile men with idiopathic oligoasthenoteratospermia: a double-blind, placebo-controlled, randomised study.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Dietary supplementation of arachidonic and docosahexaenoic acids improves cognitive dysfunction.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Omega-3 supplementation in mild to moderate Alzheimer's disease: effects on neuropsychiatric symptoms.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Depleted red cell membrane essential fatty acids in drug-treated schizophrenic patients

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Fatigue, inflammation, and ω-3 and ω-6 fatty acid intake among breast cancer survivors

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Cardiovascular effects of marine omega-3 fatty acids.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Neurodevelopmental quotient of healthy term infants at 4 months and feeding practice: the role of long-chain polyunsaturated fatty acids

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Docosapentaenoic acid (22:5n-3): a review of its biological effects.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Dietary n-3 long chain polyunsaturated fatty acids in allergy prevention and asthma treatment

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Eicosapentaenoic acid (EPA) from highly concentrated n-3 fatty acid ethyl esters is incorporated into advanced atherosclerotic plaques and higher plaque EPA is associated with decreased plaque inflammation and increased stability.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Combined ω3 and ω6 supplementation in children with attention-deficit hyperactivity disorder (ADHD) refractory to methylphenidate treatment: a double-blind, placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Omega-3 fatty acids, lipid rafts, and T cell signaling

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Maternal fish oil supplementation in pregnancy reduces interleukin-13 levels in cord blood of infants at high risk of atopy

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

A consideration of biomarkers to be used for evaluation of inflammation in human nutritional studies

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Marine omega-3 fatty acids and coronary heart disease.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Dose-response effects of fish-oil supplementation in healthy volunteers

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Temporal changes in human skeletal muscle and blood lipid composition with fish oil supplementation.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Stearidonic acid as a supplemental source of ω-3 polyunsaturated fatty acids to enhance status for improved human health.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Omega-3 fatty acids and coronary heart disease risk: clinical and mechanistic perspectives

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART).

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Dietary intake of long-chain omega-3 polyunsaturated fatty acids: contribution of meat sources

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

n-3 fatty acids, inflammation and immunity: new mechanisms to explain old actions

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

A comparison of the 12-year mortality and predictive factors of coronary heart disease among Japanese men in Japan and Hawaii

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Omega-3 fatty acids in major depressive disorder. A preliminary double-blind, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Encapsulated fish oil enriched in alpha-tocopherol alters plasma phospholipid and mononuclear cell fatty acid compositions but not mononuclear cell functions

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

The effect of omega-3 polyunsaturated fatty acid supplementation on emotional dysregulation, oppositional behaviour and conduct problems in ADHD: A systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Docosapentaenoic acid derived metabolites and mediators - The new world of lipid mediator medicine in a nutshell

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Nutritional intervention with fish oil provides a benefit over standard of care for weight and skeletal muscle mass in patients with nonsmall cell lung cancer receiving chemotherapy

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Omega-3 fatty acid treatment of children with attention-deficit hyperactivity disorder: A randomized, double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

The essentiality of long chain n-3 fatty acids in relation to development and function of the brain and retina.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Low serum cholesteryl ester-docosahexaenoic acid levels in Alzheimer's disease: a case-control study.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Fatty acids and immune function: relevance to inflammatory bowel diseases.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Incorporation of fatty acids from fish oil and olive oil into colonic mucosal lipids and effects upon eicosanoid synthesis in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

The modification of mammalian membrane polyunsaturated fatty acid composition in relation to membrane fluidity and function

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Modulation of immune function by dietary fatty acids

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Influence of marine n-3 polyunsaturated fatty acids on immune function and a systematic review of their effects on clinical outcomes in rheumatoid arthritis.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Understanding omega-3 polyunsaturated fatty acids

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Meta-analysis and meta-regression of omega-3 polyunsaturated fatty acid supplementation for major depressive disorder.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

A randomized double-blind, placebo-controlled study of the effects of supplementation with highly unsaturated fatty acids on ADHD-related symptoms in children with specific learning difficulties.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Omega-3 polyunsaturated fatty acid levels in the diet and in red blood cell membranes of depressed patients

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Efficacy of omega-3 fatty acid supplements (eicosapentaenoic acid and docosahexaenoic acid) in the secondary prevention of cardiovascular disease: a meta-analysis of randomized, double-blind, placebo-controlled trials

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Omega-3 fatty acids in cardiac biopsies from heart transplantation patients: correlation with erythrocytes and response to supplementation

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Plasma and brain fatty acid profiles in mild cognitive impairment and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Omega-3 Polyunsaturated Fatty Acid (Fish Oil) Supplementation and the Prevention of Clinical Cardiovascular Disease: A Science Advisory From the American Heart Association.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Effect of different antilipidemic agents and diets on mortality: a systematic review

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

OMEGA, a randomized, placebo-controlled trial to test the effect of highly purified omega-3 fatty acids on top of modern guideline-adjusted therapy after myocardial infarction

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Marine Oil Supplements for Arthritis Pain: A Systematic Review and Meta-Analysis of Randomized Trials.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Short-term effects of fish-oil supplementation on heart rate variability in humans: a meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

Fatty acid composition of brain phospholipids in aging and in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1017%2FS0029665117003950

7 January 2021

10.1017/S0029665117003950

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29039280%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

1 reference